Breast Cancer care is progressing at a rapid pace and with an increasing requirement for interdisciplinary collaboration, highly nuanced cross-discipline expertise and required understanding of advances in breast cancer biology. The first edition ofBreast Surgical Techniques and Interdisciplinary Management introduced a text of considerable breadth and depth. This second edition updates general areas but also more fully addresses the accelerating nuances in care. While other texts continue to force the reader to "dig" for relevant information that is often dispersed across several chapters, the editors have retained the content delivery in a focused fashion that enable the reader to quickly grasp the key concepts that is problem-based. The obvious benefit to the reader is the ability to take away actionable information in much shorter time period and with a much higher retention rate. This makes the text of considerable value for those who require "must have" knowledge in as short a time period as possible. This text continues to deliver content that is easily readable with key points absorbed clearly and rapidly. The new chapters most importantly add topics that are of essential importance to the breast cancer specialist, including our "new world" and highly important method of evaluating physician performance; breast cancer stem cells as a unifying concept for breast cancer care and therapy; next-gen sequencing to more clearly understand the specific genetic and other biologic variables that will likely impact care for individual patients; the changing surgical management of axillary nodes; more nuanced information regarding targeted systemic therapies; evolving roles of accelerated forms of radiation as well as areas where radiotherapy is potentially replacing surgery; the increasing importance of psychosocial care and palliative care, both as the "right" thing to do as a an overall movement in general cancer care. There is no other text available which brings this material together in such an accessible fashion to the student, resident, fellow, clinician in the early stages of their career or to those who are "re-tooling" the focus of their career. Even seasoned clinicians will find "pearls" in the text in areas outside their particular expertise.
Professionalism.- Multidisiciplinary Care.- Team Members and Roles.- Hx
and CBE: Likely benign vs likely malignant findings.- Documentation and Legal
Issues.- Practice Management.- Patient Satisfaction Scoring Systems.- Career
Development for Breast Surgery.- Breast Pain.- Gynecomastia.- Nipple
Discharge.- Breast Infections.- Breast Mass.- Axillary Mets w/o Primary.-
Eval during Preg.- Incorporating the Family History into the Workup.-
Hormonal Therapy and Breast Cancer Risk.- Office Based Diagnostic
Procedures.- Breast Ultrasound in the Surgeons Office as an Adjunct to the
Clinical Exam, Diagnostic Procedures, and Therepeutic Excisions.-
Ductoscopy.- Breast Cytology.- Evolving Role of Mammography, US.- Breast
MRI.- Focus on Imaging of the Axilla for Pathologic Nodes.- Special
Considerations for Breast Imaging following Augmentation or Breast
Reconstruction.- Image Guided Breast Biopsy of the Breast and Regional Nodes:
FNA vs Core, Marker vs No Marker.- Technical Considerations in Percutaneous
biopsy for Metastatic Disease.- Future Possibilities for Functional Imaging
of Breast Cancer.- Imaging for Metastatic Disease: Bone scans, CT scans, and
PET/CT.- Breast Imaging, Navigating Complex CBE and Multiple Imaging
Abnormalities.- Biology of Br CA - Overview.- Benign Histology (including
current recs for "borderline lesions", PASH, and radial scar).- Gene
Expression Profiling of Breast Cancer.- Subtypes of Triple Negative
(ER/PR/Her2) Breast Cancer.- Lessons from Next-Gen Sequencing in Breast
Cancer.- Heterogeneity of the Primary Breast Tumor and Metastatic Disease.-
Breast Cancer Stem Cells: A Unifying Theory.- How Important is Timing the
Initiation of Breast Cancer Care.- Assessing Extent of Disease in Primary
Breast Cancer.- Fertility Issues.- AJCC Staging.- Breast Cancer Treatment
Guidelines.- Clinical Trial Overview, Cooperative Groups, and the Importance
of Clincial Trial Enrollment.- iSPY and iSPY 2: a Novem Mechanism for
Clinical Trial Design.- Assessing Patient Distress.- Supportive Care.-
Psychiatric and Psychologic Issues, Introducing the Concept of Palliative
Care.- Anesthesia Issues.- Incisional, Excisional, and Wire Localized Breast
Biopsy.- Lumpectomy.- Is There Emerging Consensus on What Constitutes and
Adequate Surgical Margin?.- Intraoperative Techniques for Assessing
Tumor-Free Margins.- Oncoplastic Techniques After Lumpectomy.- Ablative
Techniques.- Total (Simple) and Modified Radical Mastectomy.- Nipple/areolar
preservation.- Plastic and Reconstructive Surgery.- Surgical Considerations
in the Very Young Breast Cancer Patient: Surgical Considerations During
Pregnancy.- When Should Patients Consider Neoadjuvant Systemic Therapy Prior
to Lumpectomy or Mastectomy?.- Special Surgical Situations: Paget's Disease.-
Special Surgical Situations: Male breast cancer.- Special Surgical
Situations: Sarcoma.- Working with Tissue Bank.- Lumpectomy or Mastectomy in
the Setting of Metastatic Disease.- Sentinel Node Bx - overview and
techniques (Radiotracer, Lymphazurin, Methyelene Blue).- Is There a Role for
Sentinel Node Biopsy Alone?.- Is Axillary Radiotherapy a Substitute for
Completion Axillary Node Dissection?.- Is there a role for Sentinel Node
Biopsy after Neoadjuvant Therapy in Patients with Clinical Resolution of
Involved Axillary Nodes?.- Surgical Technique for a Level I/II Axillary Node
Dissection.- Reverse Axillary Mapping to Avoid Lymphedema.- Components of
Breast Path Report.- Path: Risk Markers.- Path: DCIS.- Path: Invasive
carcinoma.- Path: Challenges in Consistency for ER/PR/Her2/Ki67 Test Results
and implications for Care.- Path: Post neoadjuvant chemotherapy.- Path:
Pathology of the Sentinel Node and Axillary Nodes.- Path: Breast Sarcoma.-
Basic Principles of Systemic Therapy.- Neoadj Hormonal Tx.- Neoadj
Chemo/Targeted Tx.- Conventional Adjuv Chemo Tx.- Targeted Therapies for Her2
positive tumors.- Targeted Therpaies for ER/PR/Her2 negative breast cancer.-
Adju Hormon Tx for Endocrine Sensitive Breast Cancer.- Special Situations:
Systemic Therapy During Pregnancy.- Special Situations: Breast Cancer in the
Elderly.- Alternative Therapies (CAM).- Bisphonphonates as an Adjunct to
Breast Cancer Care.- Prin Radiobiology.- APBI Overview.- Brachytherapy
Technique.- MammoSite Technique.- 3D Conformal Technique.- Single Fraction
Breast IORT.- Breast IORT as the Boost Dose.- Conventional Post Lump WB XRT.-
Current Role of Hypofractionated WB-XRT.- What are Appropriate Indications
for Post Surgical Regional Nodal Irradiation.- Controversial issues in breast
radiotherapy.- Patient Tracking Systems.- Follow up Strategies after Breast
Cancer Treatment.- Clinical Breast Exam in Treated Patients.- Diagnostic
Workup in Patients with Prior Breast Conservation.- Mgmt Options with
Ipsilateral Breast Tumor Recurrence.- Pregnancy After Br Ca.- Measuring
Quality of Breast Cancer Care.- Survivorship Issues.- Chronic Pain Issues
after Breast Surgery.- Managing Lymphedema.- Mgmt Pts with Metastases.- When
Medical Treatment Is Unable to Halt Disease Progression: (Re)introducing
Palliative Care and Appropriate Timing for Hospice.
Frederick M. Dirbas, MD Associate Professor of Surgery, Stanford University Medical Center, Stanford Cancer Institute, Palo Alto, CA, USA
Carol E.H. Scott-Conner, MD, PhD Professor of Surgery, University of Iowa Carver College of Medicine, Holden Comprehensive Cancer Center, Iowa City, IA, USA
